Company DNA
Performance-Driven
About
Artemis Medicare is a company in the corporate sector, listed on NSE as ARTEMISMED. With a market cap of ₹4K Cr and revenue of —, it is currently in the High Growth phase. Known for its Performance-Driven culture and Fast-Follower approach to innovation, the company operates at a Steady-Marathon pace. Healthcare service provider emphasizing operational efficiency and patient-outcome metrics under professional MD leadership. Its strategic mandate: Needs aggressive footprint expansion and brand scaling to compete in the rapidly consolidating private healthcare sector.
FAQ
What kind of company is Artemis Medicare?
Artemis Medicare is a null null company (ARTEMISMED) in the High Growth phase with a market cap of ₹4K Cr. It is classified as Performance-Driven in culture.
What is Artemis Medicare's culture and work environment like?
Artemis Medicare has a Performance-Driven culture with Fast-Follower innovation DNA and a Steady-Marathon pace of execution. Employee brand: Learning Ground. Customer relationship style: Premium-Niche. Healthcare service provider emphasizing operational efficiency and patient-outcome metrics under professional MD leadership.
Who leads Artemis Medicare?
Artemis Medicare is led by Dr. Devlina Chakravarty (Managing Director), a Pragmatic leader with 33 years of experience.
Culture & Strategy
CulturePerformance-Driven
InnovationFast-Follower
PaceSteady-Marathon
PurposePurpose-Blended
CustomerPremium-Niche
EmployeeLearning Ground
BrandTrusted
LifecycleHigh Growth
Healthcare service provider emphasizing operational efficiency and patient-outcome metrics under professional MD leadership.
Mandate
Needs aggressive footprint expansion and brand scaling to compete in the rapidly consolidating private healthcare sector.
Needs aggressive footprint expansion and brand scaling to compete in the rapidly consolidating private healthcare sector.
Financials
Revenue FY25—
PAT FY25—
Rev CAGR 5Y—
OPM—
NPM—
ROE—
ROCE—
P/E98.4
Fwd P/E27.1
P/B4
D/E31.4
Mkt Cap₹4K Cr
Promoter81%
Institutional1.8%
Similar Culture
Could You Lead Artemis Medicare?
Take the Genome Benchmark →